LAROSA, MADDALENA

LAROSA, MADDALENA  

Università di Padova  

Mostra records
Risultati 1 - 20 di 41 (tempo di esecuzione: 0.039 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 2024 Gerardi, Maria ChiaraFavaro, MariaTonello, MartaLarosa, MaddalenaZen, Margherita + RMD OPEN - -
Complement levels during the first trimester predict disease flare and adverse pregnancy outcomes in systemic lupus erythematosus: A network meta-analysis on 532 pregnancies 2023 Iaccarino, LucaLarosa, Maddalena + AUTOIMMUNITY REVIEWS - -
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) 2022 Emmi G.Gerosa M.Hoxha A.Larosa M.Raffeiner B. + THROMBOSIS AND HAEMOSTASIS - -
Evaluation of lupus anticoagulant, damage, and remission as predictors of pregnancy complications in lupus women: the French GR2 study 2022 Larosa, MaddalenaDoria, Andrea + RHEUMATOLOGY - -
Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis 2022 Margherita, ZenEnrico, FuzziRoberto, DepascaleMariele, GattoMaddalena, LarosaFrancesca, SacconLuca, IaccarinoAndrea, Doria + RHEUMATOLOGY - -
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study 2022 Larosa, MaddalenaIaccarino, LucaDoria, Andrea + LUPUS SCIENCE & MEDICINE - -
THE ROLE OF PENTRAXIN-3 AS PREDICTOR OF PREGNANCY COMPLICATIONS IN PATIENTS WITH SLE AND/OR ANTI-PHOSPHOLIPID SYNDROME AND APL CARRIERS 2022 LAROSA, MADDALENA - - -
Are remission and low disease activity state ideal targets for pregnancy planning in Systemic Lupus Erythematosus? A multicentre study 2021 Larosa, MaddalenaIaccarino, LucaDoria, Andrea + RHEUMATOLOGY - -
Belimumab: a step forward in the treatment of systemic lupus erythematosus 2021 Depascale R.Gatto M.Zen M.Saccon F.Larosa M.Zanatta E.Bindoli S.Doria A.Iaccarino L. EXPERT OPINION ON BIOLOGICAL THERAPY - -
Definition of Low Disease Activity State based on the SLE-DAS: Derivation and validation in a multicentre real-life cohort 2021 Larosa, MaddalenaDoria, Andrea + RHEUMATOLOGY - -
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 2021 Gatto M.Saccon F.Bartoloni E.Benvenuti F.Emmi G.Gasparotto M.Gerli R.Gerosa M.Govoni M.Larosa M.Zen M.Doria A.Iaccarino L. + JOURNAL OF AUTOIMMUNITY - -
Evaluation of the severe preeclampsia classification criterion for antiphospholipid syndrome in a study of 40 patients 2021 Larosa M.Doria A. + ARTHRITIS RESEARCH & THERAPY - -
Evaluation of the severe preeclampsia classification criterion for antiphospholipid syndrome in a study of 40 patients 2021 Larosa M.Ruffatti A.Doria A. + ARTHRITIS RESEARCH & THERAPY - -
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 2021 Doria, AndreaLarosa, Maddalena + CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY - -
SLE-DAS in the First Trimester of Gestation Predicts Maternal Lupus Flares Later in Pregnancy 2021 Larosa M.Iaccarino L.Doria A. + FRONTIERS IN PHARMACOLOGY - -
SLE-DAS in the First Trimester of Gestation Predicts Maternal Lupus Flares Later in Pregnancy 2021 Larosa M.Iaccarino L. + FRONTIERS IN PHARMACOLOGY - -
Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) enables accurate and user-friendly definitions of clinical remission and categories of disease activity 2021 Larosa M.Zen M.Iaccarino L.Doria A. + EARD - -
Comparable efficacy with similarly low risk of hypoglycaemia in patient- vs physician-managed basal insulin initiation and titration in insulin-naïve type 2 diabetic subjects: The Italian Titration Approach Study 2020 Avogaro A.Larosa M. + DIABETES/METABOLISM RESEARCH AND REVIEWS - -
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 2020 Gatto, MarieleSaccon, FrancescaZen, MargheritaTincani, AngelaBortoluzzi, AlessandraPiga, MatteoVacca, AngeloGerli, RobertoLarosa, MaddalenaIaccarino, LucaDoria, Andrea + ARTHRITIS & RHEUMATOLOGY - -
Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion 2020 Zen, MargheritaBenvenuti, FrancescoGatto, MarieleSaccon, FrancescaLarosa, MaddalenaIaccarino, LucaDoria, Andrea + RHEUMATOLOGY - -